Advertisement
U.S. markets open in 3 hours 35 minutes

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
34.06-1.35 (-3.80%)
At close: 04:00PM EDT
34.30 +0.24 (+0.69%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close35.41
Open35.40
Bid36.50 x 900
Ask36.57 x 1200
Day's Range34.03 - 35.52
52 Week Range16.95 - 49.50
Volume930,031
Avg. Volume1,479,416
Market Cap2.782B
Beta (5Y Monthly)1.80
PE Ratio (TTM)N/A
EPS (TTM)-1.72
Earnings DateMay 08, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est49.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BEAM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Beam Therapeutics Inc.
    SDGR: Lowering target price to $21.00SCHRODINGER INC has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more